Skip to main content
Clinical Trials/ACTRN12616001682437
ACTRN12616001682437
Not yet recruiting
Phase 2

Anodal dorsolateral prefrontal cortex (DLPFC) tDCS combined with pain cognition training for fibromyalgia: A pilot randomised control trial

Bernadette Fitzgibbon0 sites40 target enrollmentDecember 7, 2016

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
Bernadette Fitzgibbon
Enrollment
40
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 7, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Bernadette Fitzgibbon

Eligibility Criteria

Inclusion Criteria

  • Patients will be included if they:
  • \- A formal diagnosis of fibromyalgia
  • \- Aged between 18 and 70 years old
  • \- Have no increase or initiation of new medication therapy in the 8 weeks prior to screening and maintain existing medication regimen throughout this study’s treatment course.

Exclusion Criteria

  • Participants who:
  • \- Have a medical history of any a neurological disorder (including epilepsy and head injury) or are currently pregnant or lactating.
  • \- Have a current DSM\-V diagnosis of any psychiatric condition; excluding depression, anxiety and PTSD, unless identified as primary disorder.
  • \- Any contraindication to transcranial electrical stimulation; including presence of metal inside the head (excluding dental work) or body.

Outcomes

Primary Outcomes

Not specified

Similar Trials